Campregher, C., Honeder, C., Chung, H., Carethers, J. M., & Gasche, C. (2010). Mesalazine Reduces Mutations in Transforming Growth Factor β Receptor II and Activin Type II Receptor by Improvement of Replication Fidelity in Mononucleotide Repeats.

Campregher, Christoph, Clemens Honeder, Heekyung Chung, John M. Carethers, e Christoph Gasche. Mesalazine Reduces Mutations in Transforming Growth Factor β Receptor II and Activin Type II Receptor By Improvement of Replication Fidelity in Mononucleotide Repeats. 2010.

Campregher, Christoph, et al. Mesalazine Reduces Mutations in Transforming Growth Factor β Receptor II and Activin Type II Receptor By Improvement of Replication Fidelity in Mononucleotide Repeats. 2010.